Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of Resistance in R/R AML? What Are the Strategies to Combine IDH Inhibitors With SoC?

228 views
May 14, 2020
Comments 0
Login to view comments. Click here to Login